Cipla takes deal route with Alvotech to enter Australian autoimmune biosimilars market: GlobalData Read more
Mylan-UpJohn merger as Viatris provides opportunity to focus on biosimilar launch and uptake Read more
Informing payers and patients of biological therapy advantages can strengthen biosimilars market Read more
Biocon Biologics to get Rs 225 cr from Tata Capital Growth Fund for 0.85 per cent equity stake Read more